Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00295139 · ClinicalTrials.gov registry record · NA
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 293
- Enrollment target
NCT00295139 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 293 participants.
The verdict
NCT00295139, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 293 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment. The researchers will also determine if adding a case management component (Critical Time Intervention; CTI) to the intervention will increase treatment engagement and retention.
Interventions
- BEHAVIORAL Critical Time Intervention (CTI)
- BEHAVIORAL Behavioral Treatment for Substance Abuse in SPMI (BTSAS)
- BEHAVIORAL Supportive Treatment in Addiction Recovery (STAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00295139
The ClinicalTrials.gov registry entry for NCT00295139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 293 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Critical Time Intervention (CTI) is the first listed.
NCT00295139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00295139 about?
NCT00295139 is a clinical study titled "Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients". The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment. The researchers will also determine if adding a case management component (Critical Time Interventi...
What is the current status of trial NCT00295139?
This trial is currently completed. It is a NA study. The enrollment target is 293 participants. The study started on 2005-01. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00295139?
The interventions under investigation include: Critical Time Intervention (CTI) (BEHAVIORAL), Behavioral Treatment for Substance Abuse in SPMI (BTSAS) (BEHAVIORAL), Supportive Treatment in Addiction Recovery (STAR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00295139?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.